Previous Close | 41.81 |
Open | 42.48 |
Bid | 43.17 x 1000 |
Ask | 50.88 x 1000 |
Day's Range | 41.41 - 44.00 |
52 Week Range | 33.80 - 56.16 |
Volume | 254,373 |
Avg. Volume | 130,183 |
Market Cap | 564.715M |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | 49.71 |
EPS (TTM) | 0.87 |
Earnings Date | Mar 02, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 48.00 |
Today we will run through one way of estimating the intrinsic value of Eagle Pharmaceuticals, Inc. ( NASDAQ:EGRX ) by...
EGRX earnings call for the period ending December 31, 2020.
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 323.26% and -0.32%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?